Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006159 |
---|---|
Receipt number | R000007074 |
Scientific Title | Phase II trial of Trastuzumab in combination with Abraxane for patients with HER2-positive metastatic breast cancer |
Date of disclosure of the study information | 2011/08/15 |
Last modified on | 2018/08/17 09:25:29 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/08/12 12:16:04 | ||
2 | Update | 2018/01/05 12:21:47 | Recruitment status Anticipated trial start date |
|
3 | Update | 2018/08/17 09:25:29 | Last follow-up date Date of closure to data entry |